Peptide Cancer Therapies
Explore peptide research and guides on peptide cancer therapies.
Peptide Cancer Therapies
Octreotide for Neuroendocrine Tumors
Octreotide LAR slowed NET progression by 58% in PROMID. How this somatostatin analog works, what the trials show, and where PRRT fits.
Peptide Cancer TherapiesSomatostatin Analogs for Carcinoid Syndrome
Octreotide and lanreotide control carcinoid flushing and diarrhea in 50-70% of patients. Here's what the PROMID, CLARINET, and ELECT clinical trials showed.